Literature DB >> 21585424

Divergent behaviour of oxidative stress markers 8-hydroxydeoxyguanosine (8-OHdG) and 4-hydroxy-2-nonenal (HNE) in breast carcinogenesis.

Peeter Karihtala1, Saila Kauppila, Ulla Puistola, Arja Jukkola-Vuorinen.   

Abstract

AIMS: To clarify the role of oxidative stress during breast carcinogenesis by studying the expression of 8-hydroxydeoxyguanosine (8-OHdG) (a marker of oxidative DNA damage) and 4-hydroxy-2-nonenal (HNE) (a marker of lipid peroxidation) during the different phases of breast carcinogenesis. METHODS AND
RESULTS: The study material consisted of a total of 219 patients: 31 with usual ductal hyperplasia (UDH), 25 with atypical ductal hyperplasia (ADH), 30 with ductal carcinoma in situ (DCIS) and 133 with invasive carcinoma. The expression of 8-OHdG and HNE were evaluated immunohistochemically. Both 8-OHdG (77.4%) and HNE (45.8%) expression was already seen in UDH lesions. Interestingly, the trend of these two immunostainings during breast carcinogenesis was diverse. 8-OHdG expression diminished significantly in invasive breast carcinomas compared to non-invasive lesions (P < 0.005 when set against non-invasive cohorts). Also within the same lesions, 8-OHdG expression was the most intensive in benign cells. Conversely, HNE immunostaining was strongest in invasive breast carcinomas (UDH versus invasive cohort, P = 0.015).
CONCLUSIONS: 4-hydroxy-2-nonenal as a marker of lipid peroxidation increases during breast carcinogenesis, reflecting the role of oxidative stress in the pathogenesis of breast cancer. However, 8-OHdG shows diminished levels in carcinomas, possibly resulting from the induction of DNA repair in these invasive lesions.
© 2011 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21585424     DOI: 10.1111/j.1365-2559.2011.03835.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  23 in total

Review 1.  The Oxygen Paradox, the French Paradox, and age-related diseases.

Authors:  Joanna M S Davies; Josiane Cillard; Bertrand Friguet; Enrique Cadenas; Jean Cadet; Rachael Cayce; Andrew Fishmann; David Liao; Anne-Laure Bulteau; Frédéric Derbré; Amélie Rébillard; Steven Burstein; Etienne Hirsch; Robert A Kloner; Michael Jakowec; Giselle Petzinger; Delphine Sauce; Florian Sennlaub; Isabelle Limon; Fulvio Ursini; Matilde Maiorino; Christina Economides; Christian J Pike; Pinchas Cohen; Anne Negre Salvayre; Matthew R Halliday; Adam J Lundquist; Nicolaus A Jakowec; Fatima Mechta-Grigoriou; Mathias Mericskay; Jean Mariani; Zhenlin Li; David Huang; Ellsworth Grant; Henry J Forman; Caleb E Finch; Patrick Y Sun; Laura C D Pomatto; Onnik Agbulut; David Warburton; Christian Neri; Mustapha Rouis; Pierre Cillard; Jacqueline Capeau; Jean Rosenbaum; Kelvin J A Davies
Journal:  Geroscience       Date:  2017-12-21       Impact factor: 7.713

Review 2.  Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance.

Authors:  S Dalleau; M Baradat; F Guéraud; L Huc
Journal:  Cell Death Differ       Date:  2013-10-04       Impact factor: 15.828

Review 3.  Altered metabolite levels in cancer: implications for tumour biology and cancer therapy.

Authors:  Lucas B Sullivan; Dan Y Gui; Matthew G Vander Heiden
Journal:  Nat Rev Cancer       Date:  2016-09-23       Impact factor: 60.716

4.  Oxidatively modified proteins as plasma biomarkers in breast cancer.

Authors:  Hongjun Jin; Don S Daly; Jeffrey R Marks; Richard C Zangar
Journal:  Cancer Biomark       Date:  2013       Impact factor: 4.388

5.  Intraductal therapy of ductal carcinoma in situ: a presurgery study.

Authors:  M Ellen Mahoney; Eva J Gordon; Jian Yu Rao; Yusheng Jin; Nola Hylton; Susan M Love
Journal:  Clin Breast Cancer       Date:  2013-05-09       Impact factor: 3.225

6.  Overexpression of HER-2/neu protein attenuates the oxidative systemic profile in women diagnosed with breast cancer.

Authors:  Vanessa J Victorino; Fernanda C Campos; Ana C S A Herrera; Andréa N Colado Simão; Alessandra L Cecchini; Carolina Panis; Rubens Cecchini
Journal:  Tumour Biol       Date:  2013-11-19

7.  Oxidative stress and lipid peroxidation products in cancer progression and therapy.

Authors:  Giuseppina Barrera
Journal:  ISRN Oncol       Date:  2012-10-17

8.  Oxidative stress specifically downregulates survivin to promote breast tumour formation.

Authors:  S Pervin; L Tran; R Urman; M Braga; M Parveen; S A Li; G Chaudhuri; R Singh
Journal:  Br J Cancer       Date:  2013-02-12       Impact factor: 7.640

Review 9.  Regulation of NF-κB-induced inflammatory signaling by lipid peroxidation-derived aldehydes.

Authors:  Umesh C S Yadav; Kota V Ramana
Journal:  Oxid Med Cell Longev       Date:  2013-04-17       Impact factor: 6.543

10.  Enhanced 4-hydroxynonenal resistance in KEAP1 silenced human colon cancer cells.

Authors:  Kyeong-Ah Jung; Mi-Kyoung Kwak
Journal:  Oxid Med Cell Longev       Date:  2013-05-22       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.